Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing new therapeutics to address the problem of vascular dysfunction to address the unmet needs of patients in three important indications: glaucoma, and chronic kidney disease, Acute Respiratory Disease Syndrome (ARDS). Mannin is raising Series A of $25 million to advance its clinical programs in ARDS, glaucoma, and chronic kidney disease.

Mannin Research logo



Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


33 in total